KLIFO is a leading North European drug development consultancy. We offer consulting and operational services across all areas of drug development. We have significant experience in partnering with international companies across pharmaceutical and biotech industries.
We offer end to end solutions across all drug development areas, including strategic project management, regulatory affairs, clinical development, clinical trial supply, quality assurance (QA), Chemistry Manufacturing and Controls (CMC) development, non-clinical development and pharmacovigilance concerning the development of pharmaceutical products. We provide strategic advice as well as operational support in all these areas, and we partner with clients on portfolio strategies, project development strategies and project execution.
With offices in Denmark, Germany, Sweden and the Netherlands, and more than 150 highly qualified staff, all with solid industry experience, we can assemble a team of experts to support the efficient advancement of your project.
Our project teams represent the full breadth of expertise, competences and experience for successfully taking our clients’ drug development projects from discovery to market.
No matter the phase, scale or therapy area, our experts can help plan, manage and execute your drug development project. Whether your organisation is challenged with time, resources or expertise, we can assemble a team of relevant expert consultants to assist you.
You can insource our consultants to your organisation or outsource your project to us. Our solutions are based on close collaboration with you and your colleagues. We strive to build flexible and trust-based partnerships in which we work as an integrated part of your team.
Through collaboration, we can harness our combined expertise and ensure proper project implementation to ensure that your organisation benefits in both the short and long term.